We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science
At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.
Bioequivalence (BE) studies are crucial in generic drug development to confirm that affordable generics are as safe and effective as
CPHI & PMEC India 2026 Schedule a Meeting With Our Experts For: GCP Audit/Monitoring GMP Audits & Consulting End to
CPHI Milan 2026 Schedule a Meeting With Our Experts For: GCP Audit/Monitoring GMP Audits & Consulting End to End Regulatory
BioChina 2026 Schedule a Meeting With Our Experts For: GCP Audit/Monitoring GMP Audits & Consulting End to End Regulatory
CPHI Middle East 2026 Schedule a Meeting With Our Experts For: GCP Audit/Monitoring GMP Audits & Consulting End to
CPHI Korea 2026 Schedule a Meeting With Our Experts For: GCP Audit/Monitoring GMP Audits & Consulting End to End
Lipinski’s Rule of 5 (Ro5) is a crucial guideline in pharmaceutical development, helping researchers evaluate a compound’s likelihood of becoming an effective oral drug. However, with the rapid evolution of therapeutic strategies, it’s worth considering the relevance of Ro5 in the current drug design landscape. Understanding Lipinski’s Rule of 5
Regulatory affairs (RA) play a crucial role in the pharmaceutical industry; ensuring products meet quality, safety, and efficacy. As the industry grow further the need for qualified professionals to bridge gaps between companies and regulators increases. This blog explores Zenovel regulatory affairs expertise, our various facets, and valuable contribution to
Navigating the world of pharmaceuticals, medical devices, and biotechnology is never straightforward. With the diversity of regulatory compliance governs the Code of Federal Regulations (CFR) – a regulatory path that shapes companies’ efforts and implements how companies long for their products to be developed, manufactured, and marketed. For companies trying
The race to deliver life-saving therapies to patients is increasingly faster and more complex. Pharmaceutical and biotech companies are faced with a dizzying list of challenges — global clinical trials, continuously changing regulations, multiple complicated therapeutic areas, and pressure to innovate. This is where Contract Research Organizations (CRO) come in:
In India, sponsors of clinical trials have vital responsibilities for the ethical, regulatory, and operational success of sponsored clinical trials. As stated in the New Drugs and Clinical Trial Rules, 2019 – and the Good Clinical Practice (GCP) guidelines issued by the Central Drugs Standard Control Organization (CDSCO), sponsors have
In our fast-paced pharmaceutical industry, organizations can no longer operate their business by not only obtaining operational excellence, but also meeting stringent regulatory compliance. A strong Quality Management System (QMS) is critical to pharmaceutical operations and product lifecycle management to maintain product safety and efficacy, and regulatory compliance. At Zenovel,
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.
